Zymeworks

2 followers

‌

Zymeworks (NYSE:ZYME) is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics.

Industries

Biotechnology

Headquarters

Vancouver, Canada

Employees

201-500

Links

Org chart

Kenneth Galbraith

Chair & CEO

Kenneth Galbraith

Collapse

Chris Astle

SVP & CFO

Daniel Dex

SVP, Corporate Secretary & General Counsel

Mark Hollywood

SVP, Technical & Manufacturing Operations

Jeffrey Smith

EVP & Chief Medical Officer

John Fann

Senior Vice President, Technical Operation/process Sciences

Barbara Schaeffler

VP, Clinical Development Operations

Lucas Donigian

VP, Business & Commercial Development

Cathie Graham

VP, Legal

Laura O’Connor

VP, Human Resources & DEI

Lindsey Foulkes

VP, Corporate Development

Josemund Menezes

MD, Early-Stage Development, Asia Pacific

Jamie Rich

Senior Director, Technology | ADC Therapeutic Development

William Ferguson

Sr. Computer Systems Validation Manager

Hollings Renton

Member Board Of Directors

Leone Patterson

CBO And CFO

Teams

+50

Research and Development Team

53 members

+15

Management And Operations Team

18 members

Leadership Team

6 members

+11

Scientific and Research Team

14 members

Finance Team

8 members

Human Resources

5 members

Offices

Similar companies

Cytokinetics

12 followers

Iovance Biotherapeutics

4 followers

Arrowhead Pharmaceuticals

4 followers

BridgeBio

3 followers

Arcus Biosciences

3 followers

REGENXBIO

3 followers

Nurix

3 followers

SSENSE

15 followers

Ataccama

6 followers

Visier

19 followers

Intelex Technologies

2 followers

Explore companies